Latest Health News

Evolution Energy Minerals (ASX:EV1) has received official clearance from Tanzania’s Mining Commission to finalise its maiden drilling contract at the Chikundo Copper Project, advancing its local content strategy with three fully Tanzanian-owned contractors shortlisted.

Pinnacle Investment Management delivered a 31.5% jump in net profit after tax to $176.7 million for FY26, boosted by full ownership of Pacific Asset Management and strong inflows across retail, institutional, and international channels.

HyTerra's McCoy-1 well production test in Kansas reveals low gas saturation but notable helium concentrations, prompting a pause on further testing at the site as the company refines its geologic hydrogen strategy.

OMG Group smashed its July sales record with net sales soaring to approximately $738,000, a 120% jump on last year, reversing typical seasonal declines and boosted by a refreshed Blue Dinosaur brand.

Stakk Ltd's combined pro forma FY2026 revenue with ParaScript has climbed to approximately A$45 million, surpassing earlier forecasts by 9%. Both companies outperformed initial revenue assumptions, setting a stronger baseline ahead of integration benefits.

Audeara has reached a key milestone as its chip-level AI licensing partnership with Optek enters commercial production, receiving initial purchase orders worth about A$31,000. This validates Audeara’s scalable fee-per-chip licensing model and sets the stage for broader applications in audio and hearing health.

Vitrafy Life Sciences reported an 80% revenue surge and halved its net loss, buoyed by US military validation and major blood network partnerships. A $32 million capital raise fuels its US commercial expansion and manufacturing scale-up.

Hot Chili Limited expands its Costa Fuego copper-gold project with significant drilling success at La Verde, underpinning a strong Preliminary Feasibility Study and strategic water infrastructure plans.

Rua Bioscience has gained regulatory approval in New Zealand for five new medicinal cannabis products, setting the stage for domestic sales and advancing its strategy to integrate local cannabis genetics.

WAM Strategic Value delivered a 9.5% investment portfolio gain in FY2026, beating the ASX All Ordinaries by 3.8%, alongside an 8.3% increase in its fully franked dividend to 6.5 cents per share.

SKS Technologies Group is set to surpass its February profit forecast with an unaudited before-tax profit of $39.3 million, driven by operational discipline and scalable growth.

Singular Health deepens US healthcare foothold with ongoing Triple-S contract talks, PNS licence expansion, and Miami-Dade educational rollout, supported by a solid $10.1 million cash reserve.